Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse-Reference-Cited by-同舟云学术

Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse

Published:2018-01-22 Issue:2 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Temmingh Henk S¹,Williams Taryn¹,Siegfried Nandi¹²,Stein Dan J¹

Affiliation:

1. University of Cape Town; Department of Psychiatry and Mental Health; Valkenberg Hospital Private Bage X1 Cape Town Western Cape South Africa 7935

2. South African Medical Research Council; Alcohol, Tobacco and Other Drug Research Unit; Tygerberg South Africa

Publisher

Wiley

Subject

Pharmacology (medical)

Reference185 articles.

1. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia;Akerele;American Journal on Addictions,2007

2. Akerele EO Biderman L Levin FR A pilot study of olanzapine/risperidone for the treatment of cocaine/marijuana use disorder in individuals with schizophrenia 64th Annual Scientific Meeting of the College on Problems of Drug Dependence;2002 Jun 8-13, Quebec, Canada 2002

3. Efficacy of atypical neuroleptics in treatment of substance use among schizophrenic individuals;Akerele;Drug and Alcohol Dependence,2002

4. Clozapine versus other antipsychotics for schizophrenia and co-occurring cannabis use disorder;Brunette;Schizophrenia Bulletin,2011

5. A randomized trial of clozapine versus other antipsychotics for cannabis use disorder in patients with schizophrenia;Brunette;Journal of Dual Diagnosis,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial;JMIR Research Protocols;2023-12-18

2. The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder;Expert Opinion on Pharmacotherapy;2023-10-10

3. Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial (Preprint);2023-09-25

4. How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit;BJPsych Bulletin;2023-09-11

5. Integrated vs non-integrated treatment outcomes in dual diagnosis disorders: A systematic review;Health SA Gesondheid;2023-04-25